Data / Form D filings / INTENSITY THERAPEUTICS, INC.
INTENSITY THERAPEUTICS, INC.: Form D filings
INTENSITY THERAPEUTICS, INC., a biotechnology company in Shelton, CT, filed 5 Form D notices with the SEC between 2013 and 2024. The latest, on December 5, 2024, reports $3.6 million sold of a $3.6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 ENTERPRISE DRIVE, SUITE 430, Shelton, CT, 06484
- Phone
- (203) 221-7381
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1567264
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | New notice | $3,649,483 | $3,649,483 | 1 | Nov 21, 2024 | sec.gov | |
| Jun 12, 2015 | New notice | $5,000,000 | $500,000 | $4,500,000 | 1 | May 18, 2015 | sec.gov |
| Dec 2, 2014 | Amendment | Indefinite | $1,750,000 | 20 | Jan 5, 2013 | sec.gov | |
| Feb 11, 2014 | Amendment | $2,000,000 | $1,000,000 | $1,000,000 | 11 | Jan 5, 2013 | sec.gov |
| Jan 18, 2013 | New notice | $1,000,000 | $175,000 | $825,000 | 2 | Jan 5, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas I.H. Dubin | Director | |
| Mark A. Goldberg | Director | |
| Joseph I.H. Talamo | Executive Officer | |
| Emer H. Leahy | Director | |
| Lewis H. Bender | Executive Officer, Director | |
| Daniel H. Donovan | Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of Dec 2, 2024 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what INTENSITY THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.